Latham & Watkins represents Figure in the financing. Figure has announced the close of a $70 million Series A funding round. The round is led by...
Figure’s $70 Million Series A Funding Round
Asda Group’s £2.27 Billion Acquisition of EG Group’s UK and Ireland Business
Kirkland & Ellis and Latham & Watkins advised Asda Group on the transaction. Asda Group, owned by the Issa brothers, investment funds managed by TDR Capital...
Shopfully’s Merger With Media Central Group
Latham advised The MEDIA Central Group and Bregal, while Orrick advised ShopFully. The MEDIA Central Group and Bregal Unternehmerkapital funds, partner of Media Central Group since 2019,...
Starry Group Holdings’ Plan of Reorganization
Latham & Watkins advises Starry Group Holdings on uncontested plan of reorganization. Starry Group Holdings, Inc., a fixed wireless broadband internet service provider, received confirmation by...
Clearway Energy Group’s Financing and Sale of California Solar and Storage Projects
Latham & Watkins advising Clearway Energy Group in financing and sale of California Solar and Storage Projects Clearway Energy Group, LLC closed approximately US$1 billion of debt...
TA Associates Strategic Growth Investment in Alpha II
Latham & Watkins advises Alpha II and existing shareholder WestView Capital Partners on TA Associates strategic Growth investment. TA Associates, a leading global private equity firm,...
U.S. Physical Therapy’s $150 Million Common Stock Offering
Latham & Watkins advises the underwriters on US$150 million offering by U.S. Physical Therapy. U.S. Physical Therapy, Inc. has announced that it has priced an underwritten...
Phathom Pharmaceuticals’ $130 Million Public Offering of Common Stock
Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock. Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and...
Ecovyst’s Secondary Offering of Common Stock Shares
Latham & Watkins advised the underwriters on Ecovyst’s secondary offering of 14,000,000 shares of common stock by a selling stockholder and repurchase of common stock. Ecovyst...
NextRoll’s $50 Million Financing Deal From Capital IP
Latham & Watkins advises NextRoll in US$50 million financing deal from Capital IP. NextRoll, the San Francisco-based marketing technology company delivering products for ambitious marketers to...
eFFECTOR Therapeutics’ $7.5 Million Registered Direct Offering
Latham & Watkins advises eFFECTOR Therapeutics in US$7.5 million registered direct offering. eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors (STRIs)...
TUI’s €2.7 Billion Credit Lines Extension Until 2026
Latham & Watkins has advised the bank consortium on the maturity extension of the €2.7 billion revolving credit facilities (RCF) for travel group TUI by a...